Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Dec;18(12):1250-1257.
doi: 10.1111/jch.12860. Epub 2016 Jun 13.

Add-On Use of Eplerenone Is Effective for Lowering Home and Ambulatory Blood Pressure in Drug-Resistant Hypertension

Kazuo Eguchi  1 , Tomoyuki Kabutoya  1 , Satoshi Hoshide  1 , Shizukiyo Ishikawa  2 , Kazuomi Kario  1
Affiliations
Randomized Controlled Trial

Add-On Use of Eplerenone Is Effective for Lowering Home and Ambulatory Blood Pressure in Drug-Resistant Hypertension

Kazuo Eguchi et al. J Clin Hypertens (Greenwich). 2016 Dec.

Abstract

The authors aimed to investigate the blood pressure (BP)-lowering ability of eplerenone in drug-resistant hypertensive patients. A total of 57 drug-resistant hypertensive patients whose home BP was ≥135/85 mm Hg were investigated. The patients were randomized to either an eplerenone group or a control group and followed for 12 weeks. The efficacy was evaluated by clinic, home, and ambulatory BP monitoring. Urinary albumin, pulse wave velocity, and flow-mediated vasodilation (FMD) were also evaluated. Home morning systolic BP (148±15 vs 140±15 mm Hg) and evening systolic BP (137±16 vs 130±16 mm Hg) were significantly lowered in the eplerenone group (n=35) compared with baseline (both P<.05), while unchanged in the control group (n=22). BP reductions in the eplerenone group were most pronounced for ambulatory awake systolic BP (P=.04), awake diastolic BP (P=.004), and 24-hour diastolic BP (P=.02). FMD was significantly improved in the eplerenone group. In patients with drug-resistant hypertension, add-on use of eplerenone was effective in lowering BP, especially home and ambulatory awake BP.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study protocol.
Figure 2
Figure 2
Changes in clinic, home and ambulatory systolic BP from the baseline.
Figure 3
Figure 3
Changes in clinic, home and ambulatory diastolic BP from the baseline.
See this image and copyright information in PMC

References

    1. Moser M, Setaro JF. Clinical practice. Resistant or difficult‐to‐control hypertension. N Engl J Med. 2006;355:385–392. - PubMed
    1. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403–1419. - PubMed
    1. Nakano M, Eguchi K, Sato T, et al. Effect of intensive salt‐restriction education on clinic, home, and ambulatory blood pressure levels in treated hypertensive patients during a 3‐month education period. J Clin Hypertens (Greenwich). 2016;18:385–392. doi: 10.1111/jch.12770. - DOI - PMC - PubMed
    1. Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low‐dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003;16:925–930. - PubMed
    1. Chapman N, Dobson J, Wilson S, et al., On behalf of the Anglo‐Scandinavian Cardiac Outcomes Trial Investigators . Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension. 2007;49:839–845. - PubMed

Publication types

LinkOut - more resources